Remdesivir does not shorten healing times, says WHO

0
1
Remdesivir does not shorten healing times, says WHO


HEALTH-CORONAVIRUS-WHO-REMDESIVIR: Coronavirus: Remdesivir does not shorten healing times, says WHO


CORONAVIRUS: REMDESIVIR DOES NOT SHORTEN HEALING TIMES, SAYS WHO


© Reuters / Amr Abdallah Dalsh
CORONAVIRUS: REMDESIVIR DOES NOT SHORTEN HEALING TIMES, SAYS WHO


GENEVA (Reuters) – Remdesivir, the experimental antiviral from US laboratory Gilead, has little or no effect on the length of hospital stay of patients with COVID-19 or on their chances of survival, according to the results of a clinical study conducted by the World Health Organization (WHO).

The treatment, one of the first to have been used to fight the disease caused by the new coronavirus, was notably one of those administered recently to US President Donald Trump.

Via his study called “Solidarity”, WHO has evaluated the effects of potential treatments including remdesivir, hydroxychloroquine, the lopinavir-ritonavir combination (an approved treatment for HIV) and interferon, on 11,266 adult patients across more than 30 countries.

The results of the study, announced Thursday by the WHO, have yet to be analyzed. They have been uploaded to the medRxiv pre-release server.

Video: Covid-19: medical staff under pressure in laboratories and technical facilities (France 24)

Covid-19: medical staff under pressure in laboratories and technical facilities

Suggested videos

  • Chopper attack in Paris: the assailant indicted for "assassination attempts" terrorists

    Chopper attack in Paris: the assailant indicted for “assassination attempts” terrorists

    France 24 logo

    France 24

  • Covid-19: in Marseille, cafes and restaurants have closed shop, angry professionals

    Covid-19: in Marseille, cafes and restaurants have closed shop, angry professionals

    France 24 logo

    France 24

  • The stabbing attack near Charlie Hebdo is "strong in symbolism"

    The stabbing attack near Charlie Hebdo is “strong in symbolism”

    France 24 logo

    France 24

  • Live: two injured in stabbing attack in Paris, two suspects arrested

    Live: two injured in stabbing attack in Paris, main author arrested

    France 24 logo

    France 24

  • A stabbing attack took place in Paris, several people injured

    A stabbing attack took place in Paris, several people injured

    France 24 logo

    France 24

  • Covid-19: the new restrictions in Guadeloupe, "a blow" for tourism

    Covid-19: the new restrictions in Guadeloupe, “a blow” for the tourism

    France 24 logo

    France 24

  • In Paris, anger against sexism is displayed on the walls

    In Paris, anger against sexism is displayed on the walls

    France 24 logo

    France 24

  • January 2015 attacks: "Terrorists are here to divide us"

    January 2015 attacks: “Terrorists are here to divide us”

    France 24 logo

    France 24

  • The world reaches 30 million infections by coronavirus

    Covid in France: more than 5,000 cases in 24 hours, new restrictions

    France 24 logo

    France 24

  • January 2015 attacks: Amédy Coulibaly, a killer "determined" and " devoid of empathy"

    January 2015 attacks: Amédy Coulibaly, a killer “determined” and ” devoid of empathy”

    France 24 logo

    France 24

  • Deployment of 5G in France: cascading ecological issues

    Deployment of 5G in France: cascading ecological issues

    France 24 logo

    France 24

  • "There, we knew that there was something serious" : six months ago, the awakening in a confined France

    “There, we knew that there was something serious” : six months ago, the awakening in a confined France

    France 24 logo

    France 24

  • When Alzheimer's patients disappear

    When Alzheimer’s patients disappear

    France 24 logo

    France 24

  • Live: Jean Castex to announce new measures to fight Covid-19 pandemic

    Covid-19 : “manifest degradation” of the situation, but Castex maintains its strategy

    France 24 logo

    France 24

  • Europeans want to relaunch dialogue with Turkey without "naivete", selon Emmanuel Macron

    Europeans want to relaunch dialogue with Turkey without “naivete”, according to Emmanuel Macron

    France 24 logo

    France 24

  • Covid-19 in France: behind the "difficult decisions", the specter of a reconfinement?

    Covid-19 in France: behind the “difficult decisions”, the specter of a reconfinement?

    France 24 logo

    France 24


NEXT VIDEO

NEXT VIDEO

Earlier this month, data from a US study on Gilead’s remdesivir showed that the treatment could shorten patients’ recovery time by five days.

Responding to a Reuters request for comment, Gilead said the WHO data “appear inconsistent” compared to those obtained from studies validating the clinical benefits of remdesivir.

“We are concerned that the data from this open global study has not undergone the rigorous review necessary to allow for constructive scientific discussion.”, added the American laboratory.

The US drug administration (FDA) authorized the emergency use of remdesivir in the United States on May 1. Since then, the use of the experimental antiviral has been authorized in several other countries.

(Deena Beasley and Stephanie Ulmer-Nebehay; French version Jean Terzian)

LEAVE A REPLY

Please enter your comment!
Please enter your name here